Notably, similar to the influence of BMAL1 overexpression on HCC growth and metastasis, SR8278 treatment reduced cell viability, colony formation, migration and invasion of MHCC97H and Hep3B cells (Figure 8A-8D). The gene discussed is BMAL1; the disease is hepatocellular carcinoma.